The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2

Journal of Experimental Medicine

Volumn 183, Issue 1, 1996, Pages 169-178

  Bell, Gregory M ^a   Fargnoli, Joseph ^b   Bolen, Joseph B ^b   Kish, Leonard ^a   Imboden, John B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CELL SURFACE RECEPTOR; PROLINE; PROTEIN TYROSINE KINASE; CD2 ANTIGEN; INTERLEUKIN 2; PEPTIDE FRAGMENT; PROTEIN KINASE LCK; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; AMINO ACID SEQUENCE; ANIMAL; ARMYWORM; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENE DELETION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN CONFORMATION; RAT; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD2; BASE SEQUENCE; CELLS, CULTURED; INTERLEUKIN-2; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MOLECULAR SEQUENCE DATA; MUTAGENESIS; PEPTIDE FRAGMENTS; PROLINE; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; SPODOPTERA; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

EID: 0029671265     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.1.169     Document Type: Article

References (45)

1. Tiefenthaler, G., T. Hunig, M.L. Dustin, T.A. Springer, and S.C. Meuer. 1987. Purified lymphocyte function-associated antigen-3 and T11 target structure are active in CD2-mediated T-cell stimulation. Eur. J. Immunol. 17:1847-1850.
2. Hahn, W.C., E. Menu, A.L.M. Bothwell, B.J. Sims, and B.E. Bierer. 1992. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science (Wash. DC). 256:1805-1807.
3. Kato, L., M. Koyanagi, H. Okada, T. Takanashi, Y.W. Wong, A.N. Barclay, A.F. Williams, K. Okamura, and H. Yagita. 1992. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J. Exp. Med. 176:1241-1249.
4. Meuer, S.C., R.E. Hussey, M. Fabbi, M. Fox, O. Acuto, K.A. Fitzgerald, J.C. Hodgon, J.P. Protentis, S.F. Schlossnun, and E.L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role of the 50 kd sheep erythrocyte receptor protein. Cell. 36:897-906.
5. Siliciano, R.F., J.C. Pratt, R.E. Schmidt, and E.L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep crythrocyte binding proton Nature (Lond.). 317:428-430.
6. Bierer, B., A. Peterson, J.C. Gorga, S.H. Herrman, and S.J. Burakoff. 1988. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J. Exp. Med. 168:1145-1156.
7. Springer, T.A., M.L. Dustin, T.K. Kishimoto, and S.D. Marlin. 1987. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu. Rev. Immunol. 5:233-252.
8. Guckel, G., C. Berek, M. Lutz, P. Altevogt, V. Schirrmacher, and B.A. Kyewski. 1991. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J. Exp. Med. 174:957-967.
9. Killeen, N., S.G. Stuart, and D.R. Littman. 1992. Development and fuction of T cells in mice with a disrupted CD2 gene. EMBO (Eur. Mol. Biol. Organ.) J. 11:4329-4336.
10. Boussiotis, V.A., G.J. Freeman, J.D. Griffin, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1994. CD2 is involved in maintainance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1665-1673.
11. Brown, M.H., D.A. Cantrell, G. Bratts, M.J. Crumpton, and M. Gulberg. 1989. The CD2 antigen associates with the T cell antigen receptor CD3 complex on the surface of human T lymphocytes. Nature (Lond.). 339:551-553.
12. Beyers, A.D., L.L. Spruyt, and A.F. Williams. 1992. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc. Natl. Acad. Sci. USA. 89:2945-2949.
13. fvn. Eur. J. Immunol. 23:2196-2201.
14. fvn in T lymphocytes. Eur. J. Immunol. 24:139-144.
15. Bockenstedt, L , M.A. Goldsmith, M. Dustin, D. Olive, T.A. Springer, and A. Weiss. 1988. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor. J. Immunol. 141:1904-1911.
16. Moingeon, P., J.L. Lucich, D.J. McConkey, F. Letourneur, B Malissen, J. Kochan, H.S. Chang, H.R. Rodewald, and E.L. Reinherz. 1992. CD3ζ dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc. Natl. Acad. Sci. USA. 89:1492-1496.
17. Alcover, A., M.J. Weiss, J.F. Daley, and E.L. Reinherz. 1986. The T11 glycoprotein is functionally linked to a calcium channel in precursor and mature T-lineage cells. Proc. Natl. Acad. Sci. USA. 83:2614-2618.
18. June, C.A., J.A. Ledbetter, P.S. Rabinovitch, P.J. Martin, P.G. Beatty, and J.A. Hansen. 1986. Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes. J. Clin. Invest. 77:1224-1232.
19. Monostori, E., D. Desai, M.H. Brown, D.A. Cantrell, and M.J. Crumpton. 1989. Activation of human T lymphocytes via the CD2 antigen results in tyrosine phosphorylation of T cell antigen receptor ζ-chains. J. Immunol. 144:1010-1014.
20. Samelson, L.E., M.C. Fletcher, J.A. Ledbetter, and C.A. June. 1990. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. J. Immunol. 145:2448-2454.
21. Chang, H., P. Moingeon, P. Lopez, H. Krasnow, C. Stebbins, and E.L. Reinherz. 1989. Dissection of the human CD2 intracellular domain. J. Exp. Med. 169:2073-2083.
22. He, Q., A.D. Beyers, A.N. Barclay, and A.F. Williams. 1988. A role in transmembrane signaling for the cytoplasmic domain of the CD2 T lymphocyte surface antigen. Cell. 54:979-984.
23. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA. 84:3365-3369.
24. Sewell, W.A., M.H. Brown, J. Dunne, M.J. Owen, and M.J. Crumpton. 1986. Molecular cloning of the T-lymphocyte glycoprotein surface CD2 (T11) antigen. Proc. Natl. Acad. Sci. USA. 83:8718-8722.
25. Koretzky, G.A, J. Picus, T. Schultz, and A. Weiss. 1991. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl. Acad. Sci. USA. 88:2037-2041.
26. lck is increased in human T cells activated via CD2. Eur. J. Immunol. 21:1967-1970.
27. Bell, G.M., J. Bolen, and J.B. Imboden. 1992. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol. Cell. Biol. 12:5548-5554.
28. lck expressed as a glutathione-S-transferase fusion protein in Sf-9 cells. Protein Expression and Purification. 4:390-397.
29. Cormack, B. 1991. Mutagenesis by the Polymerase Chain Reaction. In Current Protocols in Molecular Biology. F.M. Ausubel, R. Brent, R.E Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors. John Wiley and Sons, Inc., New York. 8 5.1-8.5.9.
30. Selden, R.F. 1987. Current Protocols in Molecular Biology. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors John Wiley and Sons, Inc. New York. 9.2.1-9.2.6.
31. Bell, G.M., W.E. Seaman, E.C. Niemi, and J.B. Imboden. 1992. The OX-44 molecule couples to signaling pathways and is associated with CD2 on rat T lymphocytes and a natural killer cell line. J. Exp. Med. 175:527-536.
32. Ren, R., B.J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science (Wash. DC). 259:1157-1161.
33. Li, N., A. Batzer, R. Daly, V. Yajnik, E. Skolnick, P. Chardin, D. Bar-Sagi, B. Margolis, and J. Schlesinger. 1993. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature (Lond.). 363:85-88.
34. Rozakis-Adcock, M., F. Ross, J. Wade, T. Pawson, and D. Bowtell. 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature (Lond.). 363:83-85.
35. Egan, S.E., B.W. Giddings, M.W. Brooks, L. Buday, A M. Sizeland, and R.A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (Lond.). 363:45-51.
36. Hahn, W.C., and B.E. Bierer. 1993. Separable portions of the CD2 cytoplasmic domain involved in signaling and ligand avidity regulation. J. Exp. Med 178:1831-1836.
37. Chang, H., P. Moingeon, R. Pedersen, J. Lucich, C. Stebbins, and E.L. Reinherz. 1990. Involvement of the PPPGHR motif in T cell activation via CD2. J. Exp. Med. 172:351-355
38. Pawson, T., and G.D. Gish. 1992. SH2 and SH3 domains: from structure to function. Cell. 71:359-362.
39. Yu, H., J.K. Chen, S. Feng, D.C. Dalgarno, A.W. Brauer, and S.L. Schreiber. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 76:933-945.
40. Superti-Furga, G., S. Fumagalli, M. Koegl, S.A. Courtneidge, and G. Draetta. 1993. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO (Eur. Mol. Biol. Organ.) J. 12:2625-2634.
41. Eck, M.J., S.K. Atwell, S.E. Shoelson, and S.C. Harrison. 1994. Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature (Lond.). 368:764-769.
42. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell. 60:755-765.
43. lck tyrosine protein kinase. Mol. Cell. Biol. 10:1853-1860.
44. - cells J. Exp Med. 173:859-868.
45. Chan, A., B. Irving, J.D. Fraser, and A. Weiss. 1991. The TCR ζ chain associates with a tyrosine kinase and upon TCR stimulation associates with ZAP-70, a 70K Mr tyrosine phosphoprotein. Proc. Natl. Acad. Sci. USA. 88:9166-9170.